Mutual Funds

Bajaj Finserv Healthcare Fund-Reg(G)
Equity | Very High | Equity - Sectoral Fund - Pharma & Health Care

11.65 -0.09
NAV(₹) as on 14/8/2026

-0.75%
1D

19.42%
1Y

-
3Y

-
5Y

Bajaj Finserv Healthcare Fund-Reg(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio: 2.56	Launch Date: 27 Dec 2024
Exit Load: 1% on or before 3M, Nil after 3M	AUM: ₹ 376.77 Crs
Lock-in: Nil	Investing Style: Large Growth
Portfolio Price To Book Value: 10.07	Min. Investment: SIP : ₹ 1,000.00 Lumpsum : ₹ 500.00
Scheme Benchmark: NA
Fund Manager: Vinay Bafna ,Bharat Hegde ,Siddharth Chaudhary

FUND OBJECTIVE

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.

LATEST ASSET & PORTFOLIO ALLOCATION		Others		Equity
as on 31/7/2026		3.41 %		96.59 %

TOP HOLDINGS

Divi's Laboratories Ltd.

9.67 %

Sun Pharmaceutical Industries Ltd.

8.87 %

Piramal Pharma Ltd.

6.60 %

Apollo Hospitals Enterprise Ltd.

6.50 %

Aurobindo Pharma Ltd.

6.13 %

Rubicon Research Ltd.

6.01 %

Torrent Pharmaceuticals Ltd.

5.48 %

Neuland Laboratories Ltd.

4.42 %

Emcure Pharmaceuticals Ltd.

4.37 %

Max Healthcare Institute Ltd.

3.80 %

See All Holding

ALLOCATION BY MARKET CAP (Equity)

ALLOCATION BY RATING (Debt & Others)

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs

63.24 %

Hospital & Healthcare Servic

18.37 %

Miscellaneous

6.01 %

Consumer Food

2.66 %

Plastic Products

2.02 %

See All Sectors

PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year	2024-25	2025-26
NAV (31/3/2026)	9.08	9.07
Net Assets (Rs Crores)	30,739.86	30,045.15
Scheme Returns(%)(Absolute)	-9.21	1.18
B'mark Returns(%)(Absolute)	NA	NA
Category Rank	95/102	40/120

RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details	Inception Date	Aum(₹ Crs)	1Y	3Y	5Y	Since Inception
HDFC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 21.42 +-0.01	4/10/2023	₹ 2,939.98	23.63%	-	-	30.64%
WOC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 16.78 +-0.05	6/2/2024	₹ 824.9	19.70%	-	-	22.80%
PGIM India Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 12.14 +-0.03	6/12/2024	₹ 111.64	21.89%	-	-	12.18%
Bajaj Finserv Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.65 +-0.09	27/12/2024	₹ 376.77	19.42%	-	-	9.83%
Baroda BNP Paribas Health and Wellness Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.69 +-0.05	27/6/2025	₹ 519.48	8.54%	-	-	6.08%
Bandhan Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.24 +-0.01	28/11/2025	₹ 319.48	-	-	-	12.37%
Kotak Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 16.66 +0.03	11/12/2023	₹ 682.39	22.53%	-	-	21.02%
ITI Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 18.03 +-0.06	8/11/2021	₹ 262.84	10.34%	18.08%	-	13.16%
Nippon India Pharma Fund(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 573.15 +-1.29	5/6/2004	₹ 9,279.11	10.32%	18.10%	13.38%	20.00%
Tata India Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 33.63 +-0.05	28/12/2015	₹ 1,541.42	8.37%	18.59%	13.82%	12.08%